These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 5109479)

  • 1. [Therapy with Progressin retard. experimental studies on metabolism].
    Hammerl H; Kränzl C; Nebosis G; Pichler O; Studlar M
    Munch Med Wochenschr; 1971 Aug; 113(33):1112-5. PubMed ID: 5109479
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of an inosite-nicotinic acid-ester on serum lipid changes in patients with vascular diseases].
    Hammerl H; Kränzl C; Pichler ; Studlar M
    Munch Med Wochenschr; 1969 Sep; 111(38):1912-6. PubMed ID: 5394857
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the influence of a mesoinosite hexanicotinic acid ester on the lipolysis and carbohydrate metabolism].
    Hammerl H; Kränzl C; Pichter O; Studlar M
    Wien Klin Wochenschr; 1968 Apr; 80(14):269-71. PubMed ID: 5697957
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of a combination of vasoactive substances on metabolism and the rheoencephalogram].
    Hammerl H; Kränzl C; Nebosis G; Pichler O; Studlar M
    Wien Klin Wochenschr; 1973 Sep; 123(37):533-8. PubMed ID: 4148002
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinico-experimental metabolic studies using a Crataegus extract].
    Hammerl H; Kränzl C; Pichler O; Studlar M
    Arztl Forsch; 1967 Jul; 21(7):261-4. PubMed ID: 5631903
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experimental lipid metabolism studies with essential phospholipids taking into account the arteriosclerosis problem].
    Hammerl H; Pichler O; Studlar M
    Wien Med Wochenschr; 1966 Apr; 116(16):348-52. PubMed ID: 5985190
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of intravenous injection of heparin and nicotinic acid on (GG) plasma glyceride-glycerol and free fatty acids (FFA) level.
    Ruzyllo E; Szostak WB; Olszak W
    Pol Med Sci Hist Bull; 1968 Apr; 11(2):52-3. PubMed ID: 5649940
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical-experimental studies on lipid metabolism using Regelan].
    Hammerl H
    Wien Klin Wochenschr; 1967 Sep; 79(39):720-2. PubMed ID: 4875575
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experiences with SPN 40150 in hyperlipidemia and arteriosclerotic circulatory disturbances (author's transl)].
    Schimert G
    MMW Munch Med Wochenschr; 1974 Feb; 116(8):389-92. PubMed ID: 4208098
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of furosemide on glucose and lipid metabolism].
    Hammerl H; Kränzl C; Nebosis G; Pichler O; Studlar M
    Wien Klin Wochenschr; 1970 Apr; 82(16):294-6. PubMed ID: 5512980
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of Intensain on lipid and carbohydrate metabolism].
    Hammerl H; Kränzl C; Nebosis G; Pichler O; Studlar M
    Med Klin; 1969 Dec; 64(51):2382-5. PubMed ID: 5381208
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies of intermediary metabolism under loading with glibenclamide].
    Schräpler P; Petrides P
    Arzneimittelforschung; 1969 Oct; 19(10):1729-31. PubMed ID: 5395375
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of cardiac glycosides on the lipid metabolism].
    Siedek H; Hammerl H; Kränzl C; Pichler O; Studlar M
    Verh Dtsch Ges Kreislaufforsch; 1968; 34():198-201. PubMed ID: 5736263
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of hyperlipoproteinemia type IIa, IIb and IV with Etofibrate retard].
    Schwartzkopff W; Schilling A; Calder D
    Med Welt; 1980 Apr; 31(14):515-20. PubMed ID: 7374415
    [No Abstract]   [Full Text] [Related]  

  • 15. [Metabolic effects of orally-administered hexobendine].
    Hammerl H; Kränzl C; Nebosis G; Pichler O; Studlar M
    Wien Klin Wochenschr; 1972 Feb; 84(7):112-4. PubMed ID: 5059856
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment with nicotinic acid. II. Clinical experience].
    Carlson LA; Orö L
    Lakartidningen; 1966 Nov; 63(45):4281-7. PubMed ID: 5978872
    [No Abstract]   [Full Text] [Related]  

  • 17. Humoral changes in arteriosclerosis. Investigations on lipids, fatty acids, ketone bodies, pyruvic acid, lactic acid, and glucose in the blood.
    SCHRADE W; BOEHLE E; BIEGLER R
    Lancet; 1960 Dec; 2(7166):1409-16. PubMed ID: 13748549
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on the metabolic effects of a parenterally administered cardiac glycoside].
    Siedek H; Hammerl H; Kränzl C; Pichler O; Studlar M
    Wien Klin Wochenschr; 1968 Aug; 80(31):585-6. PubMed ID: 5704255
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experimental metabolic studies with an insulin-free pancreas extract].
    Hammerl H; Kränzl C; Nebosis G; Pichler O; Siedek H; Studlar M
    Wien Klin Wochenschr; 1971 Jun; 83(25):462-7. PubMed ID: 5130899
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental studies of the modification of myocardial metabolism with oxyfedrin].
    Niessner H; Lujf A; Moser K
    Z Gesamte Exp Med Einschl Exp Chir; 1969; 151(2):163-74. PubMed ID: 5357616
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.